Accordingly, the accumulation of phosphorylated form of the RPS6, a typical downstream product of the mTOR pathway is one of the most frequent events in head and neck squamous cell carcinoma (HNSCC) especially in OSCC (8, 10). This evidence concerns the gene RPS6 and head and neck squamous cell carcinoma.